You are here

A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Scottsdale, Arizona, 85259 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Huntington Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
30 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Have clinical features of HD and a CAG polyglutamate repeat expansion ≥ 36

- Have cognitive impairment as noted by the following:

1. A Screening MMSE AND a baseline (pre-dose) MMSE score between 10 and 26
(inclusive); and

2. A subjective assessment of cognitive impairment with decline from pre-HD levels
by the Investigator after interviewing the subject and caregiver;

- Are willing and able to give informed consent

- Aged 30 years or older

- Have a caregiver who assists/spends time with the subject at least five days per week
for at least three hours per day and has intimate knowledge of the subject's
cognitive, functional, and emotional states, and of the subject's personal care.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Had onset of symptoms prior to age 18

- Have any major medical illness or unstable medical condition within 180 days of
screening that may interfere with the subject's ability to comply with study
procedures and abide by study restrictions, or with the ability to interpret safety
data

NCT00920946
Pfizer
Completed
A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer's Disease, Huntington Disease
NCT00988624
All Genders
18+
Years
New Haven, Connecticut
Alzheimer Disease, Huntington Disease
NCT00831506
All Genders
18+
Years
New Haven, Connecticut
Huntington Disease, Alzheimer Disease
NCT00788047
All Genders
18+
Years
New Haven, Connecticut
Huntington Disease
NCT00920946
All Genders
30+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

Clini[email protected]

Call Now